Outcomes of Self-Expanding Covered Stents for the Treatment of External ILIAC Artery Obstructive Disease

Abstract

Purpose To describe the early results and mid-term patency rates of external iliac artery (EIA) stenting using self-expanding covered stents. Methods We conducted a multicenter retrospective study (2015–2021), including patients receiving primary endovascular treatment of external iliac artery occlusive disease with self-expanding covered stents. All patients were treated with the Viabahn (W.L Gore & Associates, Inc., Flagstaff, AZ–USA) stent. Patency and limb salvage rates were estimated with Kaplan–Meier curves. Results Ninety-three patients (mean age, 69 ± 9 years; 81% males) were treated for disabling claudication in 44%, rest pain in 28%, and tissue loss in 28%. TASC C/D lesions were present in 72% and iliac complete occlusion in 30%. Mean lesion length was 6.9 ± 2.4 cm; 30% had moderate/severe EIA calcifications; and the mean iliac tortuosity index was 1.17 ± 0.13. Technical success was 100%. There was one perioperative death (1.4%) and procedural complication rate was 6.5%. At 42 months (mean, 25 months), primary patency was 89.8% (95%CI 83–98); the presence of EIA tortuosity (tortuosity index > 1.25, 87.7 ± 11% vs 89.9 ± 8%; P = .6) or severe calcifications (87.6 ± 9% vs 96.0 ± 8%; P = .400) had no significant impact. After univariate analysis, the use of a stent with diameter < 8 mm (HR 8.5, 95%CI 3.24–14.22; P < .001) was negatively associated with primary patency. Conclusions The use of self-expanding covered stents provided excellent early and mid-term results in the treatment of obstructive disease of the EIA, also in cases of high EIA tortuosity and high grade of calcifications. The use of a < 8 mm-diameter stent was associated with a reduced primary patency.

Viabahn endoprosthesis for femoropopliteal aneurysm repair: safety, success rates, and long-term patency

“…In both instances of stent graft occlusion observed in our study, the patients exhibited cardiovascular risk factors and impaired distal run-off. Additionally, one patient had a smaller device diameter of 6 mm, which had previously been demonstrated to be associated with a reduced primary patency [ 27 ]. The findings of our study, including technical and clinical success as well as patency, demonstrate the efficacy of endovascular strategies, particularly for patient populations with underlying health conditions or complex anatomy requiring minimally invasive treatment.…”

The Role of Post-Surgery Rehabilitation for Patients With Multilevel Peripheral Artery Disease

“…Во многом это связано с высокой встречаемостью критической ишемии конечности, техническими трудностями осуществления полноценного восстановления кровообращения и высоким риском развития осложнений, обусловленных ишемической болезнью сердца и нарушением мозгового кровообращения [1]. Перечисленные особенности МПАБ и вовлечение в патологический процесс сосудов различных бассейнов кровообращения определяют особые требования к реабилитации данной категории больных [2,3,4].…”

Do We Really Need Expensive Stent-Grafts to Treat External Iliac Artery Lesions Effectively?

“…We read the work of Squizzato et al with great interest [ 1 ]. They reported a multicenter retrospective cohort of 93 patients with steno-occlusive lesions at the external iliac artery (EIA) treated using self-expandable covered stent (Viabahn, W.L Gore & Associates, Inc., Flagstaff, AZ-USA).…”